Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome-Reference-Cited by-同舟云学术

Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

Published:2023-10 Issue: Volume:237 Page:109602
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Alonso Cristina,Satta Valentina,Hernández-Fisac Inés,Fernández-Ruiz Javier^ORCID,Sagredo Onintza^ORCID

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference53 articles.

1. Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome;Alonso;Neuropharmacology,2022

2. Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome;Anderson;J. Nat. Prod.,2019

3. Cannabichromene, related phytocannabinoids, and 5-fluoro-cannabichromene have anticonvulsant properties in a mouse model of Dravet syndrome;Anderson;ACS Chem. Neurosci.,2021

4. Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy;Anderson;Br. J. Pharmacol.,2021

5. Antioxidative and anti-inflammatory properties of cannabidiol;Atalay;Antioxidants,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARγ;Neurochemistry International;2024-07

2. A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a mouse model of Dravet syndrome;Prostaglandins & Other Lipid Mediators;2024-06

3. Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model;Pharmaceuticals;2024-04-07

4. Cannabidiol and epilepsy;International Review of Neurobiology;2024